Occam Places CEO Shakti Narayan, JD, PhD for Oncology Biotech Accent Therapeutics
In September 2019, Occam recruited Shakti Narayan, JD, PhD, as Chief Executive Officer of Accent Therapeutics. Narayan is a highly accomplished and very evolved biotech strategy and business development leader with a long suit in oncology.
Narayan most recently served as the Chief Business Officer at Tango Therapeutics, where he was responsible for finance, business development, and operational functions. While at Tango, he led a partnership with Gilead Sciences valued at $1.7 billion, which proved transformational. Prior to his work at Tango, Narayan was the VP and Head of Transactions at Johnson & Johnson Innovation, where he helped establish J&J's Innovation Centers model and led oncology business development. Narayan began his biotech career in business development at Genentech.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.